Hanin Pharma SRL
Hanin Pharma reported total assets of €3.62m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026).
The score of Hanin Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +64 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hanin Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 12 Aug 2022
Hanin Pharma's financial analysis
- Solvency32.0%sector median: 60.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hanin Pharma
Hanin Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0725.714.606
- VAT number
- BE0725714606
- Peppol
- Registered · 0208:0725714606 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Apr 2019
- Registered office
- 1090 Jette
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Hanin Pharma (SRL) has been based in Jette since 2019, active in: activities of holding companies. For 2025, it reports a net profit of 142,985 € and equity of €1.16m; its revenue is not published. Its solvency stands at 32.0%, below the median of its sector (60.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hanin Pharma
Companies in the same business, of comparable size and area, outside its group.
- Decath Holding Activities of holding companies Wortegem-Petegem · balance sheet €3.62m
- Vandapower Group Activities of holding companies Ghent · balance sheet €3.62m
- Five Aces Activities of holding companies Hamme (Vl.) · balance sheet €3.62m
- Twabo Activities of holding companies Oudenaarde · balance sheet €3.62m
- Savabo Activities of holding companies Oostkamp · balance sheet €3.62m
- Pandox Belgium Activities of holding companies Saint-Josse-ten-Noode · balance sheet €3.62m
- Partfin Activities of holding companies Saint-Nicolas · balance sheet €3.63m
- Henry Pharma Activities of holding companies Pont-à-Celles · balance sheet €3.63m
Frequently asked questions about Hanin Pharma
What is the revenue of Hanin Pharma?
Hanin Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hanin Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0725714606 for Hanin Pharma, if the company is VAT-registered. Its company number (CBE) is 0725.714.606.
Where is the registered office of Hanin Pharma?
According to the CBE register, the registered office of Hanin Pharma is in 1090 Jette.
What is the equity of Hanin Pharma?
At the close of the 2025 financial year, the equity of Hanin Pharma amounts to 1,159,761 €, a solvency of 32.0% of total assets.
Who manages Hanin Pharma?
The register lists 1 active mandates at Hanin Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hanin Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →